u/aleksi_eriksen

Australia here. Waited 13 months on a list, gave up, went private, and the total cost was roughly what I expected.

Yeah, data logger is the only acceptable proof.

data logger is the standard, gut feeling is not

amylin is not GLP-1, posts conflating them get corrected

dose-stretching experiences welcome, dose-stretching instructions are not

glucagon-receptor contribution is appetite for dual and triple agonism

The half-life is 7 hours, which means week 7 is genuinely still ramp-up. Week 38 is steady state.

no tracking numbers, no full addresses, no label photos — instant removal

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Small correction: the trial was 18 weeks, not 14. Does not change your point but people will quote it.

Strongly agree. Peak temperature is not the whole story.

Half-life is about 168 hours, so steady state lands around week 17–5. Practical consequence: what you feel in week 1 is not what that dose does.

no images, none, not even redacted ones

Disagree on that part. 96.8% and 96.2% on the same vial is normal.

the 12-day half-life means week 12 is still ramp-up pharmacokinetically

Stalled for 17 weeks, changed nothing, and it started moving again on week 56.

Strongly agree. Peak temperature is not the whole story.

Which country? Half the answers in this thread only apply in Germany.

Half-life is about 168 hours, so steady state lands around week 8–5.

Adding to this: milestone is doing more work than the comment implies.

the related substances line is where the story is

the maintenance question changes at maintenance

Every time this gets posted it hits the front page and every time someone has to re-explain it.